These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10611190)

  • 1. Relationships of serum pro-inflammatory cytokines and vascular endothelial growth factor with liver dysfunction in severe ovarian hyperstimulation syndrome.
    Chen CD; Wu MY; Chen HF; Chen SU; Ho HN; Yang YS
    Hum Reprod; 2000 Jan; 15(1):66-71. PubMed ID: 10611190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of serum and follicular fluid cytokine profile in the prediction of moderate to severe ovarian hyperstimulation syndrome.
    Chen CD; Chen HF; Lu HF; Chen SU; Ho HN; Yang YS
    Hum Reprod; 2000 May; 15(5):1037-42. PubMed ID: 10783347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of interleukin-2, soluble interleukin-2 receptor alpha, interleukin-6, soluble interleukin-6 receptor and vascular endothelial growth factor in serum and ascitic fluid of patients with severe ovarian hyperstimulation syndrome.
    Aboulghar MA; Mansour RT; Serour GI; El Helw BA; Shaarawy M
    Eur J Obstet Gynecol Reprod Biol; 1999 Nov; 87(1):81-5. PubMed ID: 10579621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries.
    Agrawal R; Conway G; Sladkevicius P; Tan SL; Engmann L; Payne N; Bekir J; Campbell S; Jacobs H
    Fertil Steril; 1998 Oct; 70(4):651-8. PubMed ID: 9797093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic importance of serial cytokine changes in ascites and pleural effusion in women with severe ovarian hyperstimulation syndrome.
    Chen CD; Wu MY; Chen HF; Chen SU; Ho HN; Yang YS
    Fertil Steril; 1999 Aug; 72(2):286-92. PubMed ID: 10438997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentration of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation syndrome.
    Ludwig M; Bauer O; Lopens A; Jelkmann W; Diedrich K
    Hum Reprod; 1998 Jan; 13(1):30-2. PubMed ID: 9512224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.
    Rizk B; Aboulghar M; Smitz J; Ron-El R
    Hum Reprod Update; 1997; 3(3):255-66. PubMed ID: 9322101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine levels in a patient with severe ovarian hyperstimulation syndrome before and after the ultrafiltration and reinfusion of ascitic fluid.
    Ito M; Harada T; Iwabe T; Tanikawa M; Terakawa N
    J Assist Reprod Genet; 2000 Feb; 17(2):118-20. PubMed ID: 10806592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of free vascular endothelial growth factor(165) (VEGF(165)) are not elevated during gonadotropin stimulation in in vitro fertilization (IVF) patients developing ovarian hyperstimulation syndrome (OHSS): results of a prospective cohort study with matched controls.
    Enskog A; Nilsson L; Brännström M
    Eur J Obstet Gynecol Reprod Biol; 2001 Jun; 96(2):196-201. PubMed ID: 11384807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome.
    Agrawal R; Tan SL; Wild S; Sladkevicius P; Engmann L; Payne N; Bekir J; Campbell S; Conway G; Jacobs H
    Fertil Steril; 1999 Feb; 71(2):287-93. PubMed ID: 9988400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum vascular endothelial growth factor levels are poorly predictive of subsequent ovarian hyperstimulation syndrome in highly responsive women undergoing assisted conception.
    Mathur R; Hayman G; Bansal A; Jenkins J
    Fertil Steril; 2002 Dec; 78(6):1154-8. PubMed ID: 12477503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor.
    Pellicer A; Albert C; Mercader A; Bonilla-Musoles F; Remohí J; Simón C
    Fertil Steril; 1999 Mar; 71(3):482-9. PubMed ID: 10065786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome.
    Abramov Y; Barak V; Nisman B; Schenker JG
    Fertil Steril; 1997 Feb; 67(2):261-5. PubMed ID: 9022600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization.
    Lee A; Christenson LK; Stouffer RL; Burry KA; Patton PE
    Fertil Steril; 1997 Aug; 68(2):305-11. PubMed ID: 9240261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum vascular endothelial growth factor levels before starting gonadotropin treatment in women who have developed moderate forms of ovarian hyperstimulation syndrome.
    D'Ambrogio G; Fasciani A; Monti M; Cattani R; Genazzani AR; Artini PG
    Gynecol Endocrinol; 1999 Oct; 13(5):311-5. PubMed ID: 10599547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome.
    Abramov Y; Schenker JG; Lewin A; Friedler S; Nisman B; Barak V
    Hum Reprod; 1996 Jul; 11(7):1381-6. PubMed ID: 8671471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor, interleukin-6 and interleukin-2 in serum and follicular fluid of patients with ovarian hyperstimulation syndrome.
    Artini PG; Monti M; Fasciani A; Battaglia C; D'Ambrogio G; Genazzani AR
    Eur J Obstet Gynecol Reprod Biol; 2002 Mar; 101(2):169-74. PubMed ID: 11858893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian hyperstimulation syndrome: pre-ovulatory serum concentrations of interleukin-6, interleukin-1 receptor antagonist and tumour necrosis factor-alpha cannot predict its occurrence.
    Loret de Mola JR; Baumgardner GP; Goldfarb JM; Friedlander MA
    Hum Reprod; 1996 Jul; 11(7):1377-80. PubMed ID: 8671470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rise of the serum level of von Willebrand factor occurs before clinical manifestation of the severe form of ovarian hyperstimulation syndrome.
    Ogawa S; Minakami H; Araki S; Ohno T; Motoyama M; Shibahara H; Sato I
    J Assist Reprod Genet; 2001 Feb; 18(2):114-9. PubMed ID: 11285978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Function of vascular endothelial growth factor in ovarian hyperstimulation syndrome].
    Liang W; Chen S; Xing F
    Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):651-3. PubMed ID: 11930687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.